{"id":61029,"date":"2024-10-28T12:05:39","date_gmt":"2024-10-28T12:05:39","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/28\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/"},"modified":"2024-10-28T12:05:39","modified_gmt":"2024-10-28T12:05:39","slug":"mbx-biosciences-to-participate-in-upcoming-november-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/","title":{"rendered":"MBX Biosciences to Participate in Upcoming November Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">CARMEL, Ind., Oct.  28, 2024  (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that its management team will participate in the following upcoming investor conferences:<\/p>\n<p><strong>Guggenheim Inaugural Healthcare Innovation Conference<\/strong><\/p>\n<p>Date: Tuesday, November 12, 2024<br \/>Format: Fireside chat<br \/>Time: 3:30 p.m. EST<br \/>Location: Boston, MA<\/p>\n<p><strong>Stifel 2024 Healthcare Conference<\/strong><\/p>\n<p>Date: Monday, November 18, 2024<br \/>Format: Fireside chat<br \/>Time: 3:00 p.m. EST<br \/>Location: New York, NY<\/p>\n<p><strong>Jefferies London Healthcare Conference<\/strong><\/p>\n<p>Date: Wednesday, November 20, 2024<br \/>Format: Company presentation<br \/>Time: 3:30 p.m. GMT<br \/>Location: London, UK<\/p>\n<p>Live webcasts can be accessed on the investors section of the MBX Biosciences website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DSAf0M-XXngRrCcZITHoMZn86DDUhAf3ff_jxmRAoAXBp5Q6Pas8WGwjG2VCfWaaM6Tg5EKVULiYEw-K1n0H3LO0aU8yGm6CLhKKrllH7hQxqWwkc2TP9ARE3ue2ibL7d3ugvXnaBya18pO8yoFlFoU9KVRW2kx2QazLVOz4hOA=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/investors.mbxbio.com\/news-events\/events<\/a>. Access to the webcast replay will be available approximately two hours after the completion of the event and will be archived on the Company\u2019s website for approximately 90 days.<\/p>\n<p><strong>About<\/strong> <strong>MBX Biosciences<\/strong><br \/>MBX Biosciences is a biopharmaceutical company focused on the discovery and development of novel precision peptide therapies based on its proprietary PEP&#x2122; platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company\u2019s pipeline includes its lead product candidate MBX 2109, in Phase 2 development for the treatment of chronic hypoparathyroidism (HP); MBX 1416, in Phase 1 development for the treatment of post-bariatric hypoglycemia (PBH); and an obesity portfolio that includes MBX 4291, as well as multiple discovery and pre-clinical candidates in development for the treatment of obesity. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AOxaXfFUvokOXNqhRsjOELdfv9Ecely2M8Gt3DKha_I1c7HsDp4naiZzUT7suUFjSapuu6kq50HInl-EC31NAg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.mbxbio.com\">www.mbxbio.com<\/a> and follow it on LinkedIn.<\/p>\n<p><strong>About <\/strong><strong>MBX\u2019s Proprietary Precision Endocrine Peptide (PEP&#x2122;) Platform<\/strong> <br \/>MBX was founded by global leaders with a transformative approach to peptide drug design and development. Leveraging this expertise, the Company designed its proprietary Precision Endocrine Peptide&#x2122; (PEP&#x2122;) platform to overcome the key limitations of unmodified and modified peptide therapies and to improve clinical outcomes and simplify disease management for patients. PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing.<\/p>\n<p><strong>Media Contact:<\/strong><br \/>Kate Burdick<br \/>Inizio Evoke Comms<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bfaVn-c4SkTpDuo2zlaUaNweb71VSDQzXXfvhXhMJVcE40sMf-ZksnFrQ1KCkXIFZn7P8MAb1zvkDaD9DAkP-MOm7LmG5NcHoLvDRStTv9-t2sOhZHs7s8l70acnFuGu\" rel=\"nofollow noopener\" target=\"_blank\" title=\"kate.burdick@inizioevoke.com\">kate.burdick@inizioevoke.com<\/a> <br \/>860-462-1569<\/p>\n<p><strong>Investor Contact:<\/strong><br \/>Jim DeNike<br \/>MBX Biosciences<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pOrUkVnsyG3Fwn4n2Gt3bK6DFoxExHdfyutHg_GkG8fQZ1_96VtnRSu-1TPxyLem9ZUu_gsWHXhNdwoO-xmbc9mv8FuE9QdwGc44C-f4LPs=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"jdenike@mbxbio.com\">jdenike@mbxbio.com<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjQyZDg2ZTQtZWNkYy00MGI3LTkxMTgtYTMwNTdhYTc1OWI1LTEyNTY5Mjc=\/tiny\/MBX-Biosciences-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CARMEL, Ind., Oct. 28, 2024 (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that its management team will participate in the following upcoming investor conferences: Guggenheim Inaugural Healthcare Innovation Conference [&#8230;]\n","protected":false},"author":1,"featured_media":61030,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MBX Biosciences to Participate in Upcoming November Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MBX Biosciences to Participate in Upcoming November Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"CARMEL, Ind., Oct. 28, 2024 (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company focused on the di\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-28T12:05:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/MBX-Biosciences-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"MBX Biosciences to Participate in Upcoming November Investor Conferences\",\"datePublished\":\"2024-10-28T12:05:39+00:00\",\"dateModified\":\"2024-10-28T12:05:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\"},\"wordCount\":411,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\",\"name\":\"MBX Biosciences to Participate in Upcoming November Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-10-28T12:05:39+00:00\",\"dateModified\":\"2024-10-28T12:05:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MBX Biosciences to Participate in Upcoming November Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MBX Biosciences to Participate in Upcoming November Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"MBX Biosciences to Participate in Upcoming November Investor Conferences","og_description":"CARMEL, Ind., Oct. 28, 2024 (GLOBE NEWSWIRE) &#8212; MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company focused on the di","og_url":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-10-28T12:05:39+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/MBX-Biosciences-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"MBX Biosciences to Participate in Upcoming November Investor Conferences","datePublished":"2024-10-28T12:05:39+00:00","dateModified":"2024-10-28T12:05:39+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/"},"wordCount":411,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/","name":"MBX Biosciences to Participate in Upcoming November Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-10-28T12:05:39+00:00","dateModified":"2024-10-28T12:05:39+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/mbx-biosciences-to-participate-in-upcoming-november-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"MBX Biosciences to Participate in Upcoming November Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61029"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61029\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61030"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}